Reply to “Comment on ‘<i>In Vivo</i> Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma’”
Ilse R. Dubbelboer(Uppsala University), Hans Lennernäs(Uppsala University), Mikael Hedeland(Swedish Veterinary Agency), Per Stål(Karolinska University Hospital), Charlotte Ebeling Barbier(Uppsala University Hospital), Torkel B. Brismar(Karolinska University Hospital), Amar Karalli(Karolinska University Hospital), Elsa Lilienberg(Uppsala University), Erik Sjögren, Ulf Bondesson(Uppsala University), Rimma Axelsson(Karolinska University Hospital), Agneta Norén(Uppsala University Hospital), Rickard Nyman(Uppsala University Hospital), Frans Duraj(Uppsala University Hospital)
Cited by 1
Related Papers
Checklist for Artificial Intelligence in Medical Imaging (CLAIM): 2024 Update
|Radiology Artificial Intelligence|2024|406
Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet – a randomised controlled trial
|JHEP Reports|2021|220
Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients
|Clinical Nutrition|2015|179